Οκτ202015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα20 Οκτωβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Τελικό Πρόγραμμα 9ου Σχολείου Κλινικής ΗπατολογίαςΕπόμενοNext post:Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis BΣχετικά ΆρθραReal-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis2 Φεβρουαρίου 2026Autoimmune liver diseases in Latin America: Current landscape and challenge29 Ιανουαρίου 2026Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)27 Ιανουαρίου 2026The 2024 diagnostic criteria for primary sclerosing cholangitis26 Ιανουαρίου 2026Impact of first and further decompensation in patients with compensated ACLD due to MASLD23 Ιανουαρίου 2026Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B21 Ιανουαρίου 2026
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis2 Φεβρουαρίου 2026
Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)27 Ιανουαρίου 2026
Impact of first and further decompensation in patients with compensated ACLD due to MASLD23 Ιανουαρίου 2026
Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B21 Ιανουαρίου 2026
